-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The latest statistics show that there are about 463 million people with diabetes worldwide, which is expected to increase to 700 million
There are 120 million people with chronic kidney disease in China
Approximately 40% of people with diabetes mellitus have chronic kidney disease
According to statistics, there are currently up to 120 million patients
It is reported that the factors affecting the progression of chronic kidney disease include unchangeable factors, such as age, sex, ethnicity, family history and duration of diabetes, as well as modifiable factors, such as blood glucose, blood pressure, proteinuria, blood lipids and lifestyle
Currently, about 40% of people with diabetes have chronic kidney disease
However, the diagnosis rate of chronic kidney disease is low, with up to 90% of patients not knowing they have the disease
Patients with chronic kidney disease should not only control blood sugar, but also reduce cardiovascular adverse events
Antihypertensive, hypoglycemic and other joint protection of the kidneys
Damage to individual organs can lead to dysfunction of other organs, which is also the leading cause
In addition, the guidelines also point out that patients with type 2 diabetes with confirmed diabetes mellitus, regardless of whether the blood glucose is up to standard, if the eGFR ≥ 45 ml · min · (1.
Recently, the first sodium-glucose synergistic transporter-2 inhibitor dapagliflozin in China has been approved for marketing